TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Cancer Biomark
; 38(1): 103-110, 2023.
Article
in En
| MEDLINE
| ID: mdl-37545223
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Cancer Biomark
Journal subject:
BIOQUIMICA
/
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands